Depreciation of Mereo BioPharma Group plc from 31 Dec 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Mereo BioPharma Group plc quarterly and annual Depreciation in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
  • Mereo BioPharma Group plc Depreciation for the quarter ending 31 Mar 2025 was $38,000, a 7.3% decline year-over-year.
  • Mereo BioPharma Group plc Depreciation for the twelve months ending 31 Mar 2025 was $140,000, a 18% decline year-over-year.
  • Mereo BioPharma Group plc annual Depreciation for 2024 was $143,000, a 16% decline from 2023.
  • Mereo BioPharma Group plc annual Depreciation for 2023 was $171,000, a 5.5% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Mereo BioPharma Group plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $140,000 $38,000 -$3,000 -7.3% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $143,000 $98,000 -$27,000 -38% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q3 2024 $170,000 $100,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $170,000 $100,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $170,000 $41,000 -$1,000 -2.4% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $171,000 $71,000 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $100,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $100,000 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $42,000 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1

Mereo BioPharma Group plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $143,000 -$28,000 -16% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
2023 $171,000 -$10,000 -5.5% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $181,000 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.